Clinical Trial Update: New Screening and Diagnostic Cut-off Points of PA Patients

View source ↗

Summary

This clinical trial update describes new screening and diagnostic cut-off points for primary aldosteronism (PA) patients. The trial, sponsored by the China Nati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aldosteronism

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Primary Aldosteronism | Status: RECRUITING